top of page

March 2021 // Science

  • Sandra Glasmacher
  • Mar 29, 2021
  • 1 min read

Updated: Oct 26, 2021

We are excited to share a scientific publication about the beneficial effect of the prototype SERI WOBE437 in a clinically relevant mouse model of Multiple Sclerosis and transient spasticity.


The article is published on ACS Pharmacology & Translational Science as the result of collaborative work between the group of Prof. J. Gertsch and Prof. B. Engelhardt at the University of Bern under the leadership of Dr. Andrea Chicca.


Find out more https://pubs.acs.org/doi/10.1021/acsptsci.0c00214



Graphic: Reynoso-Moreno et al., 2021.

Recent Posts

See All
March 2025 // Communication

Synendos has been selected as a finalist of the Swiss Economic Award 2025 in the category Deeptech / Life Sciences. LinkedIn post

 
 
March 2025 // Events & Communication

Synendos has been selected for the Bio-Neuroscience Award for the "Best Pitch" after our CEO Andrea Chicca's presentation on our clinical...

 
 
July 2024 // Communication

Synendos is excited to announce the publication of the latest article written by Andrea Chicca and Jürg Gertsch, “CNS Drug Discovery in...

 
 
bottom of page